Life Science Seminar – Wrap up from our event last week – Thursday the 31st. of August.
Life Science Seminar – Wrap up from our event last week – Thursday the 31st. of August.
Life Science Seminar – Wrap up from our event last week – Thursday the 31st. of August.
We hosted 11 Life science companies from Sweden and Denmark. They presented their equity story and insights into their pipeline.
The M&A activity in the sector is stable due to a couple of large deals in 2023, but in this low-risk environment operational financing becomes more and more of a challenging. Many of the companies showed medical progression and to a supportive valuation.
Listen to our brief introduction: Life Science Seminar
The following companies participated:
Bavarian Nordic – Emergent Pharma company with strong vaccine portfolio.
Gubra – Profitable CRO business and strong Obesity pipeline.
Expres2ion Biotechnologies – Proof of concept VLP technology in vaccines.
Ascelia Pharma – Orphan oncology company with phase 3 project Orviglance.
Pharma Equity Group – Owner of portfolio company Reponex with a repositioning strategy.
Curasight – Biotech company pioneering in the development of intelligent cancer imaging and more gentle and efficient treatment of cancer.
Bioporto – The company focuses on improving the quality of life with actionable biomarkers, the company’s flagship product is the NGAL-TEST.
Hansa Biopharma – Addressing urgent unmet needs within rare diseases.
Qlife – Medtech company - products branded under Egoo Health – Point of care testing equipment with CRP assay.
InDex Pharmaceuticals - Swedish pharmaceutical company seeking to improve the lives of patients suffering from immunological diseases – with Phase 3 project Cobitolimod.
NeoDynamics – Medtech company - they created an innovative precision biopsy system called NeoNavia based on the pulse technology aiming at cancer treatment.
HC Andersen Capital receives payment from all companies in this post for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 08:50 AM 05-09-2023.